by palligoelme@gmail.com | May 14, 2026 | Clinical Trials
Conditions: Healthy Participants Interventions: Drug: Povorcitinib; Drug: Ruxolitinib Sponsors: Incyte Corporation Recruiting Conditions: Healthy Participants Interventions: Drug: Povorcitinib; Drug: Ruxolitinib Sponsors: Incyte Corporation...
by palligoelme@gmail.com | May 14, 2026 | Clinical Trials
Conditions: Ophthalmology; Artificial Intelligence (AI); Hepatobiliary Diseases; Systemic Diseases Interventions: Diagnostic Test: Systemic diseases such as Hepatobiliary Disorders Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University; Third Affiliated...
by palligoelme@gmail.com | May 14, 2026 | Clinical Trials
Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia; Chemotherapy-Induced Thrombocytopenia; Gynecologic Cancers; Ovarian Cancer; Breast Cancer; Lung Cancer; Non-Small Cell Lung Cancer; Cervical Cancer; Fallopian Tube Cancer; Primary Peritoneal...
by palligoelme@gmail.com | May 14, 2026 | Clinical Trials
Conditions: Hearing Loss, Adult-Onset; Tinnitus Interventions: Device: Artificial Intelligence (AI) Assisted Clinical Decision Support Tool for managing Hearing Loss and Tinnitus Sponsors: Royal Cornwall Hospitals Trust; University of Exeter; University of...
by palligoelme@gmail.com | May 14, 2026 | Clinical Trials
Conditions: Cirrhosis; Splenectomy; Status; Hypersplenism; Kidney Function Issue Sponsors: Northern Jiangsu People’s Hospital Not yet recruiting Conditions: Cirrhosis; Splenectomy; Status; Hypersplenism; Kidney Function Issue Sponsors: Northern Jiangsu...